Advertisement
Canada markets close in 38 minutes
  • S&P/TSX

    21,982.82
    +97.44 (+0.45%)
     
  • S&P 500

    5,110.25
    +61.83 (+1.22%)
     
  • DOW

    38,290.32
    +204.52 (+0.54%)
     
  • CAD/USD

    0.7319
    -0.0004 (-0.06%)
     
  • CRUDE OIL

    83.77
    +0.20 (+0.24%)
     
  • Bitcoin CAD

    87,280.10
    -1,057.84 (-1.20%)
     
  • CMC Crypto 200

    1,333.12
    -63.42 (-4.54%)
     
  • GOLD FUTURES

    2,350.40
    +7.90 (+0.34%)
     
  • RUSSELL 2000

    2,003.14
    +22.02 (+1.11%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,955.56
    +343.80 (+2.20%)
     
  • VOLATILITY

    14.99
    -0.38 (-2.47%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     

Analysts Remain Bullish on Nektar Stock in August

Analysts Remain Bullish on Nektar Stock in August

Nektar Therapeutics (NKTR), a research-focused biopharmaceutical company, is developing a strong pipeline of product candidates that make use of its polymer conjugate technology platforms. This pipeline includes investigational drugs for the treatment of cancer, autoimmune disease, and chronic pain.